Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for the ...

The first phase 3 randomised clinical trial of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy and ...

UK MHRA grants marketing approval to Lilly's Kisunla to treat mild cognitive impairment and mild dementia due to Alzheimer's disease: Indianapolis Thursday, October 24, 2024, 09:0 ...

Indian clinical research companies go hitech to streamline patient recruitment & predict accurate outcomes: Nandita Vijayasimha, Bengaluru Thursday, October 24, 2024, 08:00 Hrs [I ...

FIHAV 40th Edition to offer key opportunities for Indian pharma companies: Our Bureau, Mumbai Thursday, October 24, 2024, 08:00 Hrs [IST] The 40th Edition of the International Tra ...

Telangana DCA sleuths seize diverted ESI Hospital drugs from medical shops: Peethaambaran Kunnathoor, Chennai Thursday, October 24, 2024, 08:00 Hrs [IST] The drug control departme ...

DoP rejects review applications from five companies on pricing of modified release metoprolol: Gireesh Babu, New Delhi Thursday, October 24, 2024, 08:00 Hrs [IST] The Department o ...

BioVersys joins EU-funded RespiriNTM Programme to accelerate development of its broad-spectrum drug candidates against NTM pulmonary diseases: Basel, Switzerland Wednesday, Octobe ...

Nuclidium announced that the first patient has been successfully imaged in a phase 1 clinical trial evaluating the company’s radiotracer candidate as a safe and accurate diagnostic and disease-staging ...

Syngene International in its second quarter has reported revenue from operations increased sequentially by 13% but down 2% year-on-year to Rs. 891 crore compared to the corresponding quarter where it ...

Find Therapeutics, clinical-stage biopharmaceutical company, announced initiation of dosing in its phase 1 clinical study of FTX-101 in healthy volunteers. FTX-101 is a first-in-class therapeutic ...

OC Academy survey indicates 93.58% of Indian doctors demand specialized upskilling beyond CME: Our Bureau, Bengaluru Wednesday, October 23, 2024, 16:40 Hrs [IST] OC Academy has in ...